Breast Cancer: Habitat imaging based on intravoxel incoherent motion for predicting pathologic complete response to
Hui Zhang1, Yunyan Zheng2, Mingzhe Zhang2
1Shengli Clinical College of Fujian Medical University & Department of Surgical Oncology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Background:
Radiomics research based on whole tumors is limited by the unclear biological significance of radiomics features, which therefore lack clinical interpretability.
Purpose:
We aimed to determine whether features extracted from subregions defined by habitat imaging, reflecting tumor heterogeneity, could identify breast cancer patients who will benefit from neoadjuvant chemotherapy (NAC), to optimize treatment.
Methods:
143 women with stage II-III breast cancer were divided into a training set (100 patients, 36 with pathologic complete response [pCR]) and a test set (43 patients, 16 with pCR). Patients underwent 3-T magnetic resonance imaging (MRI) before NAC. With the pathological results as the gold standard, we used the training set to build models for predicting pCR based on whole-tumor radiomics (ModelWH), intravoxel incoherent motion (IVIM)-based habitat imaging (ModelHabitats), conventional MRI features (ModelCF), and immunohistochemical findings (ModelIHC). We also built the combined models ModelHabitats+CF and ModelHabitats+CF+IHC. In the test set, we compared the performance of the combined models with that of the invasive ModelIHC by using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA). Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive value of the model. The DeLong test was used to compare diagnostic efficiency across different parameters.
Results:
In the prediction of pCR, ModelWH, ModelHabitats, ModelCF, ModelIHC, ModelHabitats+CF, ModelCF+IHC and ModelHabitats+CF+IHC achieved AUCs of 0.895, 0.757, 0.705, 0.807, 0.800, 0.856, and 0.891 respectively, in the training set and 0.549, 0.708, 0.700, 0.788, 0.745, 0.909, and 0.891 respectively, in the test set. The DeLong test revealed no significant difference between ModelIHC versus ModelHabitats+CF (p = 0.695) and ModelHabitats+CF+IHC versus ModelCF+IHC (p = 0.382) but showed a significant difference between ModelIHC and ModelHabitats+CF+IHC (p = 0.043).
Conclusion:
The habitat model we established from first-order features combined with conventional MRI features and IHC findings accurately predicted pCR before NAC. This model can facilitate decision-making during individualized treatment for breast cancer.
More Related Videos
Related Concept Videos
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging


